Get started
ONCIMMUNE HLDGS PLC ORD GBP0.01ONCIMMUNE HLDGS PLC ORD GBP0.01ONCIMMUNE HLDGS PLC ORD GBP0.01

ONCIMMUNE HLDGS PLC ORD GBP0.01

No trades
See on Supercharts
Overview
Financials
News Ideas Discussions Technicals Seasonals

ONC fundamentals

Key facts

Market capitalization—
Dividend yield (indicated)—
Price to earnings Ratio (TTM)—
Basic EPS (TTM)—
Founded—
Employees (FY)—
CEO—
Website—
About

Oncimmune Holdings Plc engages in diagnosing cancer. It is involved in the development, manufacture and commercialisation of personalised immunodiagnostics for the screening, detection and care of cancer. The company's operating segment includes Early CDT Lung and ImmunoINSIGHTS. The company was founded in 2002 and is headquartered in Nottinghamshire, the United Kingdom.

Valuation

Fundamental metrics to determine fair value of the stock

Summary
No data available
There's currently no market capitalization, revenue or net income data to show.
Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

No dividends
ONC has never paid dividends and has no current plans to do so.

Financial health

Financial position and solvency of the company